Our Partnership Prospectus for 2023 is live.
FPM is a trusted provider of in-person, online and hybrid events.
Anchored by our 30+ year history and our mission to advance the science and practice of pharmaceutical medicine for the benefit of the public, we are able to attract highly influential speakers to our meetings. Household names such as Whitty, Van Tam, Türeci and Goldacre have all accepted invitations to speak at our events on our reputation alone.
Our events portfolio is managed by a mature and award-winning events team headed by a dedicated Events Manager and supported by colleagues in marketing, policy and communications, and education – not forgetting our Chief Executive Marcia Philbin – as well as a rolling list of volunteers from our membership.
- We are now excited to offer opportunities for organisations who share our vision to support our events throughout 2023.
Share our stage
On top of all the usual brand placement and exhibition opportunities, our Gold Partners* will also qualify for a Spotlight5 speaking slot at one of our two largest annual events. Spotlight5 offers a five-minute window for approved partners to present a short case study or solution to a common problem that pharmaceutical physicians face.
*Gold partnership is the top-tier sponsorship available for FPM Annual Symposium and FPM Education Day
New to FPM?
Do you want a quick and easy way to target physicians working in medicines development? We’ve already done that market segmentation for you! FPM’s 1600 members are a unique cohort of doctors who work in the development of drugs. They are the people who ensure that medicines and medical devices are safe and effective for patients and the public.
FPM’s events bring together groups of these individuals under one roof to hear about cutting edge technologies, gain new insights from subject area experts, and participate in topical debates. Over the past three years alone we have attracted some incredibly high-profile speakers including Professor Sir John Bell, Dame June Raine, Professor Sir Chris Whitty and Professor Ben Goldacre.